112 related articles for article (PubMed ID: 24658949)
21. Distribution of normal nuchal translucency thickness: a multicenter study in Thailand.
Kor-Anantakul O; Suntharasaj T; Suwanrath C; Chanprapaph P; Sirichotiyakul S; Ratanasiri T; Vuthiwong C; Geater A
Gynecol Obstet Invest; 2011; 71(2):124-8. PubMed ID: 21150163
[TBL] [Abstract][Full Text] [Related]
22. The effect of nuchal cord on nuchal fold thickness measured in the second trimester.
Özkavukcu E; Haliloğlu N
Eur J Radiol; 2012 Feb; 81(2):e123-5. PubMed ID: 21296515
[TBL] [Abstract][Full Text] [Related]
23. [Increased nuchal translucency with normal karyotype].
Senat MV; Frydman R
Gynecol Obstet Fertil; 2007 Jun; 35(6):507-15. PubMed ID: 17521948
[TBL] [Abstract][Full Text] [Related]
24. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
25. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and perinatal outcome of dichorionic and monochorionic twins with nuchal translucency above the 99(th) percentile and normal karyotype.
Goncé A; Borrell A; Meler E; Arigita M; Martínez JM; Botet F; Sánchez A; Gratacós E
Ultrasound Obstet Gynecol; 2010 Jan; 35(1):14-8. PubMed ID: 20033999
[TBL] [Abstract][Full Text] [Related]
27. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.
Bromley B; Shipp TD; Lyons J; Navathe RS; Groszmann Y; Benacerraf BR
J Ultrasound Med; 2014 Oct; 33(10):1737-45. PubMed ID: 25253819
[TBL] [Abstract][Full Text] [Related]
28. Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation.
Cheng PJ; Chang SD; Shaw SW; Soong YK
Obstet Gynecol; 2005 May; 105(5 Pt 1):1058-62. PubMed ID: 15863545
[TBL] [Abstract][Full Text] [Related]
29. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
30. Does nuchal translucency thickness in the first trimester predict GDM onset during pregnancy?
Luchi C; Schifano M; Nanini C; Di Cianni G; Lencioni C; Genazzani AR
Gynecol Endocrinol; 2011 Oct; 27(10):782-4. PubMed ID: 21190419
[TBL] [Abstract][Full Text] [Related]
31. Fetal nuchal translucency scan in Nigeria.
Oloyede OA; Abbey M; Oloyede AA; Nwachukwu O
Pan Afr Med J; 2014; 18():62. PubMed ID: 26113896
[TBL] [Abstract][Full Text] [Related]
32. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
33. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
Sepulveda W; Wong AE; Dezerega V
Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
[TBL] [Abstract][Full Text] [Related]
34. Nuchal translucency-based Down syndrome screening: barriers to implementation.
Malone FD
Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
[TBL] [Abstract][Full Text] [Related]
35. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
36. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
[TBL] [Abstract][Full Text] [Related]
37. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
38. Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies.
Shamshirsaz AA; Salmanian B; Ravangard SF; Shamshirsaz AA; Javadian P; Borgida A; Turner G; Feldman D; Spiel M; Benn P; Campbell WA
J Matern Fetal Neonatal Med; 2014 Mar; 27(5):495-9. PubMed ID: 23806115
[TBL] [Abstract][Full Text] [Related]
39. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
Whitlow BJ; Economides DL
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonographic assessment of fetal nuchal translucency (NT) at 11th and 14th week of gestation--Polish multicentre study.
Czuba B; Borowski D; Cnota W; Sieroszewski P; Grettka K; Pietryga M; Wyrwas D; Czekierdowski A; Włoch A; Wielgós M; Jaczyńska R; Kaminski P; Brazert J; Szaflik K; Sodowski K
Neuro Endocrinol Lett; 2007 Apr; 28(2):175-81. PubMed ID: 17435666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
